Form 8-K - Current report:
SEC Accession No. 0001193125-22-146413
Filing Date
2022-05-10
Accepted
2022-05-10 16:59:18
Documents
17
Period of Report
2022-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d298928d8k.htm   iXBRL 8-K 33147
2 EX-10.1 d298928dex101.htm EX-10.1 1909277
3 EX-10.2 d298928dex102.htm EX-10.2 1553317
4 EX-99.1 d298928dex991.htm EX-99.1 12105
8 GRAPHIC g298928g0510031614880.jpg GRAPHIC 2980
9 GRAPHIC g298928g0510031615240.jpg GRAPHIC 2879
  Complete submission text file 0001193125-22-146413.txt   4443175

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220505.xsd EX-101.SCH 2534
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220505_lab.xml EX-101.LAB 18035
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220505_pre.xml EX-101.PRE 11326
11 EXTRACTED XBRL INSTANCE DOCUMENT d298928d8k_htm.xml XML 3449
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22910777
SIC: 2834 Pharmaceutical Preparations